Lido Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Lido Advisors's RMD Position: Q3 2026 in Review
Lido Advisors increased its ResMed (RMD) stake by 79% in Q3 2026, buying an estimated $362K and bringing the position to 3,772 shares worth $834K. The position accounts for ﹤0.01% of the portfolio, ranked #1183.
Lido Advisors first reported a position in RMD in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.23M in Q3 2025. 442 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Lido Advisors held 3,772 shares of ResMed worth $834K as of Q3 2026.
- Lido Advisors bought 1,660 ResMed shares in Q3 2026, an estimated $362K.
- ResMed made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #1183 holding.
- Lido Advisors first reported a position in ResMed in Q2 2020 and has held it in 23 quarters since.
- Lido Advisors's ResMed position peaked at $1.23M in Q3 2025.
- 442 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.